Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Heinrich Dreismann, Harry Glorikian, Mary Alice McMorrow, Gerald Cox, and More

Heinrich Dreismann and Harry Glorikian

In a filing with the US Securities and Exchange Commission, Interpace Diagnostics announced the resignations of Heinrich Dreismann and Harry Glorikian from the company's board of directors. The company stated that neither resignation was due to a disagreement with the company or matters relating to the company's operations, policies, or practices.


Mary Alice McMorrow

Good Start Genetics has appointed Mary Alice McMorrow as vice president of marketing. She will be responsible for leading the company's marketing activities in each of its three markets: clinical, consumer, and pediatric. Most recently, McMorrow led brand development and consumer communications at a Boston-based startup in the creative entertainment category. Previously, she has managed well-known global brands, including Stride Rite, Playskool, Safety 1st, and Always brands.


Gerald Cox, Kenneth LeClair, and Semiramis Trotto

Editas Medicine has expanded its senior management team by appointing Gerald Cox as chief medical officer, Kenneth LeClair as vice president of technical development and manufacturing, and Semiramis Trotto as vice president of human resources. Cox has held senior clinical development roles at Sanofi Genzyme (formerly Genzyme) for over 15 years. He most recently served as vice president of rare disease clinical development at Sanofi Genzyme. Cox also continues to serve in a part-time role as staff physician in genetics at Boston Children's Hospital. LeClair joins Editas from Novartis Pharmaceuticals, where he served as executive director of technical research and development of the cell and gene therapies unit. He has also worked as a postdoctoral research fellow at the MIT Center for Cancer Research and as an assistant professor of medicine at the Beth Israel Deaconess Medical Center at Harvard Medical School. Trotto comes to Editas from Baxalta, where she most recently served as the vice president of human resources in oncology. Before her time at Baxalta she spent over a decade at Bristol-Myers Squibb where she was responsible for human resources across a number of different business function in the US and internationally.


For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.